A Randomized Controlled Trial of Self‐Guided Digital Written Imaginal Exposure Therapy for Eating Disorders in Patients Recently Discharged From Higher Level Specialty Eating Disorder Care
International Journal of Eating Disorders · 2026-10 · 59 (10) · 2317-2331
DOI: 10.1002/eat.70147 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift International Journal of Eating Disorders, online erschienen am 11.06.2026. Verfasst von Cheri A Levinson und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychological & Brain Sciences, University of Louisville, Louisville, Kentucky, USA. Hauptthemen laut MEDLINE: Implosive Therapy, Feeding and Eating Disorders, Fear. Die Arbeit nennt 49 Literaturangaben. Gefördert von: U.S. Department of Health and Human Services.
Abstract (Originalsprache)
Objective
Imaginal exposure therapy facilitates the approach of feared stimuli (e.g., fear of weight gain) not accessible in everyday life (e.g., rapidly gaining weight) and has initial promising data for the treatment of eating disorders (EDs).
Methods
In the current randomized controlled trial (RCT) participants ( N = 130) were randomly assigned to a five‐session digital imaginal exposure condition or a control online journaling condition within 4 months of discharge from intensive (e.g., inpatient) treatment. We examined the feasibility and acceptability of the treatment conditions, target engagement, and initial clinical efficacy. This study was pre‐registered.
Results
Imaginal exposure therapy significantly outperformed the control condition on our primary outcome and target mechanism: fear of weight gain. Imaginal exposure therapy also outperformed the control condition on overall ED symptoms, fear of food, food avoidance, clinical impairment, and PTSD symptoms, suggesting initial clinical efficacy.
Discussion
This RCT suggests that the active ingredient (i.e., exposure to feared stimuli) in imaginal exposure leads to significant decreases in fear of weight gain and associated clinical outcomes. This work supports imaginal exposure therapy as an effective intervention for fear of weight gain, a primary maintenance factor of EDs. Trial Registration NCT04862247
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychological & Brain Sciences, University of Louisville, Louisville, Kentucky, USA.
- Department of Pediatrics, Division of Child and Adolescent Psychiatry and Psychology, University of Louisville, Louisville, Kentucky, USA.
- Department of Biostatistics, University of Louisville, Louisville, Kentucky, USA.
ORCID-Profile: Cheri A Levinson, Taylor Penwell, Luis E Sandoval-Araujo, Morgan Johnson, Allison Grady, Jayson Stancil, Maiying Kong
Förderung
- U.S. Department of Health and Human Services
Zitieren
APA
Levinson, C. A., Penwell, T., Sandoval-Araujo, L. E., Johnson, M., Grady, A., Stancil, J., & Kong, M. (2026). A Randomized Controlled Trial of Self‐Guided Digital Written Imaginal Exposure Therapy for Eating Disorders in Patients Recently Discharged From Higher Level Specialty Eating Disorder Care. International Journal of Eating Disorders, 59(10), 2317-2331. https://doi.org/10.1002/eat.70147
Vancouver
Levinson CA, Penwell T, Sandoval-Araujo LE, Johnson M, Grady A, Stancil J, et al. A Randomized Controlled Trial of Self‐Guided Digital Written Imaginal Exposure Therapy for Eating Disorders in Patients Recently Discharged From Higher Level Specialty Eating Disorder Care. International Journal of Eating Disorders. 2026;59(10):2317-2331. doi:10.1002/eat.70147
BibTeX
@article{Levinson2026,
author = {Levinson, Cheri A and Penwell, Taylor and Sandoval-Araujo, Luis E and Johnson, Morgan and Grady, Allison and Stancil, Jayson and Kong, Maiying},
title = {A Randomized Controlled Trial of Self‐Guided Digital Written Imaginal Exposure Therapy for Eating Disorders in Patients Recently Discharged From Higher Level Specialty Eating Disorder Care},
journal = {International Journal of Eating Disorders},
year = {2026},
volume = {59},
number = {10},
pages = {2317--2331},
doi = {10.1002/eat.70147}
}
EUVIMED